Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Pfizer Inc. stock logo
PFE
Pfizer
$25.73
-1.0%
$26.28
$24.48
$31.54
$145.79B0.6140.13 million shs37.26 million shs
Redfin Co. stock logo
RDFN
Redfin
$10.38
+6.4%
$7.97
$5.10
$15.29
$1.31B2.96.04 million shs18.12 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Pfizer Inc. stock logo
PFE
Pfizer
-2.36%+1.10%+0.94%+2.96%-8.35%
Redfin Co. stock logo
RDFN
Redfin
-0.10%+53.70%+17.59%+1.35%+36.31%
Remove Ads

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Pfizer Inc. stock logo
PFE
Pfizer
4.8914 of 5 stars
2.33.04.24.22.83.33.1
Redfin Co. stock logo
RDFN
Redfin
3.1228 of 5 stars
2.12.00.03.22.42.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Pfizer Inc. stock logo
PFE
Pfizer
2.50
Moderate Buy$31.9224.09% Upside
Redfin Co. stock logo
RDFN
Redfin
2.17
Hold$9.48-8.72% Downside

Current Analyst Ratings Breakdown

Latest RDFN and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/11/2025
Redfin Co. stock logo
RDFN
Redfin
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Neutral$4.00 ➝ $12.50
3/11/2025
Redfin Co. stock logo
RDFN
Redfin
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
3/10/2025
Redfin Co. stock logo
RDFN
Redfin
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
3/6/2025
Redfin Co. stock logo
RDFN
Redfin
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$7.00 ➝ $4.00
3/5/2025
Redfin Co. stock logo
RDFN
Redfin
Zelman & Associates
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/3/2025
Redfin Co. stock logo
RDFN
Redfin
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$10.00 ➝ $7.00
3/3/2025
Redfin Co. stock logo
RDFN
Redfin
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$8.00 ➝ $7.00
2/19/2025
Redfin Co. stock logo
RDFN
Redfin
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$7.25 ➝ $7.25
2/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$33.00 ➝ $33.00
1/28/2025
Pfizer Inc. stock logo
PFE
Pfizer
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$30.00 ➝ $29.00
(Data available from 3/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.29$4.03 per share6.38$15.81 per share1.63
Redfin Co. stock logo
RDFN
Redfin
$1.04B1.26N/AN/A$0.02 per share519.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4118.248.490.6412.62%19.47%8.09%4/29/2025 (Estimated)
Redfin Co. stock logo
RDFN
Redfin
-$130.03M-$1.37N/AN/AN/A-14.88%N/A-13.28%5/6/2025 (Estimated)

Latest RDFN and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.69%+2.50%121.99%16 Years
Redfin Co. stock logo
RDFN
Redfin
N/AN/AN/AN/AN/A

Latest RDFN and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/12/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.78%1/24/20251/24/20253/7/2025
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
Redfin Co. stock logo
RDFN
Redfin
N/A
1.50
1.50

Institutional Ownership

CompanyInstitutional Ownership
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Redfin Co. stock logo
RDFN
Redfin
61.07%

Insider Ownership

CompanyInsider Ownership
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Redfin Co. stock logo
RDFN
Redfin
4.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.67 billion5.66 billionOptionable
Redfin Co. stock logo
RDFN
Redfin
4,693126.39 million118.53 millionOptionable

Recent News About These Companies

Piper Sandler Upgrades Redfin (RDFN)
Redfin Co. stock logo
Redfin (NASDAQ:RDFN) Shares Gap Down - Time to Sell?
Redfin Co. stock logo
Redfin (NASDAQ:RDFN) Lowered to Hold Rating by B. Riley
Redfin's (RDFN) "Hold" Rating Reiterated at Needham & Company LLC
Redfin upgraded to Hold from Underperform at Gordon Haskett
Redfin Co. stock logo
Redfin (NASDAQ:RDFN) Shares Gap Up - Still a Buy?
America's Wealthiest 1% Could Buy 99% of America's Homes
Redfin skyrockets, Novo Nordisk drops, Tesla: Market Minute

New MarketBeat Followers Over Time

Media Sentiment Over Time

Pfizer stock logo

Pfizer NYSE:PFE

$25.72 -0.27 (-1.02%)
Closing price 03:59 PM Eastern
Extended Trading
$25.76 +0.03 (+0.12%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Redfin stock logo

Redfin NASDAQ:RDFN

$10.38 +0.62 (+6.35%)
Closing price 04:00 PM Eastern
Extended Trading
$10.42 +0.03 (+0.34%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates and sells mortgages. In addition, the company uses digital platforms to connect consumers with rental properties. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.